(Q24197534)

2

0 references

Peter Jüni

4

0 references

author name string

Bruno R da Costa

1

0 references

Anne WS Rutjes

Cochrane Database of Systematic Reviews

5

0 references

publication date

14 November 2012

0 references

published in

0 references

cites work

Experience with a placebo-controlled randomized clinical trial of a disease-modifying drug for osteoarthritis: the doxycycline trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Varus malalignment negates the structure-modifying benefits of doxycycline in obese women with knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Comparison of quantitative and semiquantitative indicators of joint space narrowing in subjects with knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Malalignment and subchondral bone turnover in contralateral knees of overweight/obese women with unilateral osteoarthritis: implications for bilateral disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

The effects of doxycycline on reducing symptoms in knee osteoarthritis: results from a triple-blinded randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Randomised, blinded, placebo controlled trial of doxycycline for chronic seronegative arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Accuracy and precision of joint space width measurements in standard and macroradiographs of osteoarthritic knees

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

A simple method for converting an odds ratio to effect size for use in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Principles of and Procedures for Systematic Reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Treatment of destructive arthritic disorders with MMP inhibitors. Potential role of tetracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

What is "quality of evidence" and why is it important to clinicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

GRADE guidelines 6. Rating the quality of evidence—imprecision

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Data extraction errors in meta-analyses that use standardized mean differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Osteoarthritis: rational approach to treating the individual

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Superiority of the Lyon schuss view over the standing anteroposterior view for detecting joint space narrowing, especially in the lateral tibiofemoral compartment, in early knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Oral or transdermal opioids for osteoarthritis of the knee or hip

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Meta-analysis: chondroitin for osteoarthritis of the knee or hip.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Joint lavage for osteoarthritis of the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Undue reliance on I(2) in assessing heterogeneity may mislead

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Transcutaneous electrostimulation for osteoarthritis of the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

S-Adenosylmethionine for osteoarthritis of the knee or hip

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Therapeutic ultrasound for osteoarthritis of the knee or hip

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Viscosupplementation for Osteoarthritis of the Knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Differential patterns of response to doxycycline and transforming growth factor beta1 in the down-regulation of collagenases in osteoarthritic and normal human chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Glucosamine therapy for treating osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Glucosamine for pain in osteoarthritis: why do trial results differ?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Fluctuation of knee pain and changes in bone marrow lesions, effusions, and synovitis on magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Doxycycline for osteoarthritis of the knee or hip

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Disease modification in osteoarthritis: Are drugs the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

7 January 2021

Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drug

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

7 January 2021

Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

7 January 2021

Association between concentrations of urinary type II collagen neoepitope (uTIINE) and joint space narrowing in patients with knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

7 January 2021

Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

7 January 2021

Methods to convert continuous outcomes into odds ratios of treatment response and numbers needed to treat: meta-epidemiological study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007323.PUB3

7 January 2021

10.1002/14651858.CD007323.PUB3

Identifiers

DOI

0 references

Fatcat ID

release_rvw3rlbf6jejli336m4svgl5tm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rvw3rlbf6jejli336m4svgl5tm

24 November 2022